Hungary vs South Korea: Cause of death, by non-communicable diseases, ages 15-59
Hungary
68.2%
in 2021
South Korea
67.9%
in 2021
Hungary rank
41st
South Korea rank
43rd
Cause of death, by non-communicable diseases, ages 15-59 over time
- Hungary
- South Korea
How they compare
Hungary currently reports 68.2% against 67.9% in South Korea, a difference of 0.3%.
Across all 6 years both countries report, Hungary has been ahead every year.
Hungary ranks 41st and South Korea ranks 43rd of 185 countries.
Hungary has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hungary | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 82.6% | 68.2% | 14.4% | Hungary |
| 2010s | 84.7% | 67.1% | 17.6% | Hungary |
| 2020s | 74.9% | 68.3% | 6.6% | Hungary |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Hungary or South Korea?
- Hungary, at 68.2% against 67.9% in South Korea as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Hungary and South Korea?
- 0.3%, with Hungary ahead.
- How many years of comparable data are there for Hungary and South Korea?
- 6 years are reported by both, from 2000 to 2021.
- How do Hungary and South Korea rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Hungary ranks 41st and South Korea ranks 43rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.